Investment thesis
Venture capital backing and incubating early-stage biotech companies.
Sesamers tracks 2 portfolio companies across 2 rounds, 1 of them as lead investor. Its most recent tracked deal: Oyster Therapeutics, Nov 2026.
Portfolio
Past investments
| Company | Round | Role | Date | Round size |
|---|---|---|---|---|
| Oyster Therapeutics London, United Kingdom Read the announcement → | Series A | Participant | Nov 2026 | €54.1M |
| Breye Therapeutics Hørsholm, Denmark Read the announcement → | Series A | Lead | Sep 2026 | €67.5M |